<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00154609</url>
  </required_header>
  <id_info>
    <org_study_id>930701</org_study_id>
    <nct_id>NCT00154609</nct_id>
  </id_info>
  <brief_title>Davallia Divaricata BL: The Use of Traditional Chinese Native Medicine for Osteoporosis</brief_title>
  <official_title>The Use Tradition Chinese Native Medicine Treats the Osteoporosis Research</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <brief_summary>
    <textblock>
      We, the investigators at National Taiwan University Hospital, have determined the therapeutic
      and toxic effects of the traditional herb on the ovariectomized Wistar rat.

      The final years will determine its effects on the therapy of women who are over 45 years old
      and postmenopausal with osteoporosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Research of this traditional chinese clinical medicine, Gusuibu, curative effect is planned
      for three years time. The entire study aims to evaluate the effect of the traditional chinese
      medicine on postmenopausal osteoporosis as well as the possible side effects on the
      experimental animal and the human body. All subjects were postmenopausal women with
      established osteoporosis.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2002</start_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The project is aimed to investigate the clinical effects of the water extract of Gu-Sui-Bu from the aspects of animal and clinic studies.</measure>
  </primary_outcome>
  <enrollment>100</enrollment>
  <condition>Osteoporosis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gu-Sui-Bu (Davallia Divaricata)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Postmenopausal osteoporosis

        Exclusion Criteria:

          -  Insulin dependent diabetes
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liu Hwa-Chang, Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>National Taiwan University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Liu Hwa-Chang, Ph.D</last_name>
    <phone>886-2-23956988</phone>
    <email>hcliu@ha.mc.ntu.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Medical Center</name>
      <address>
        <city>Taipei</city>
        <state>7, Chung-Shan South Road</state>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liu Hwa-Chang, Ph.D</last_name>
      <phone>886-2-23956988</phone>
      <email>hcliu@ha.mc.ntu.edu.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>January 2002</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2005</study_first_submitted>
  <study_first_submitted_qc>September 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2005</study_first_posted>
  <last_update_submitted>January 20, 2006</last_update_submitted>
  <last_update_submitted_qc>January 20, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 23, 2006</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

